Search for Clinical Trial Results

Sponsored By

Acute Promyelocytic Leukemia - 34 Studies Found

Status Study
Completed Study Name: Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
Condition: Acute Promyelocytic Leukemia
Date: 2007-04-25
Interventions: Drug: AIDA
Completed Study Name: Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
Condition: Acute Promyelocytic Leukemia
Date: 2006-12-05
Interventions:
  • Drug: ATRA 45 mg/m2 day until

Completed Study Name: Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
Condition: Acute Promyelocytic Leukemia
Date: 2017-01-24
Interventions: Other: QoL questionnaires Quality of life questionnaires
Completed Study Name: Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)
Condition: Acute Promyelocytic Leukemia
Date: 2016-09-04
Interventions:
  • Drug: Realgar-Indigo naturalis formula

Completed Study Name: Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Date: 2016-03-02
Completed Study Name: Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Date: 2007-08-16
Interventions: Drug: Single agent arsenic trioxide duration of maintenance therapy, 6 months versus 12 months
Completed Study Name: Proteasome Inhibition in Acute Promyelocytic Leukemia
Condition: Relapsed Acute Promyelocytic Leukemia
Date: 2013-09-22
Interventions: Drug: Bortezomib Combination of arsenic trioxide with bortezomib in the treatment of relapsed acute prom
Recruiting Study Name: Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Date: 2008-05-07
Interventions: Drug: NRX 195183 Soft Gelatin Capsule Daily oral NRX 195183 administration for 90 days to assess CR rate
Completed Study Name: Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Date: 2016-02-11
Interventions:
  • Drug: Arsenic trioxide Other N
Completed Study Name: Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic
Condition:
  • Relapsed Acute Promyelocytic Leukemia
  • Refractory
  • Drug: Arsenic trioxide
  • Drug: Trisenox
Next >>>